EUVIMEDEUVIMED entdecken
Multizentrische StudieOpen Access

Major Adverse Kidney Events in Pediatric Continuous Kidney Replacement Therapy

Dana Y Fuhrman, Erin K Stenson, Issa Alhamoud, Rashid Alobaidi, Gabriella Bottari, Sarah Fernandez, Francesco Guzzi, Taiki Haga, Ahmad Kaddourah, Eleonora Marinari, Tahagod H Mohamed, Catherine J Morgan und 11 weitere

JAMA Network Open · 2024

DOI: 10.1001/jamanetworkopen.2024.0243 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift JAMA Network Open, 2024. Verfasst von Dana Y Fuhrman und 22 weiteren Autor:innen. Beteiligte Einrichtung: University of Pittsburgh Medical Center Children's Hospital of Pittsburgh, Pittsburgh, Pennsylvania. Hauptthemen laut MEDLINE: Acute Kidney Injury, Renal Dialysis. Die Arbeit wurde bisher 34-mal zitiert (Crossref) und nennt 28 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIGMS NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Importance Continuous kidney replacement therapy (CKRT) is increasingly used in youths with critical illness, but little is known about longer-term outcomes, such as persistent kidney dysfunction, continued need for dialysis, or death.

Objective

To characterize the incidence and risk factors, including liberation patterns, associated with major adverse kidney events 90 days after CKRT initiation (MAKE-90) in children, adolescents, and young adults. Design, Setting, and Participants This international, multicenter cohort study was conducted among patients aged 0 to 25 years from The Worldwide Exploration of Renal Replacement Outcomes Collaborative in Kidney Disease (WE-ROCK) registry treated with CKRT for acute kidney injury or fluid overload from 2015 to 2021. Exclusion criteria were dialysis dependence, concurrent extracorporeal membrane oxygenation use, or receipt of CKRT for a different indication. Data were analyzed from May 2 to December 14, 2023. Exposure Patient clinical characteristics and CKRT parameters were assessed. CKRT liberation was classified as successful, reinstituted, or not attempted. Successful liberation was defined as the first attempt at CKRT liberation resulting in 72 hours or more without return to dialysis within 28 days of CKRT initiation. Main Outcomes and Measures MAKE-90, including death or persistent kidney dysfunction (dialysis dependence or ≥25% decline in estimated glomerular filtration rate from baseline), were assessed.

Results

Among 969 patients treated with CKRT (529 males [54.6%]; median [IQR] age, 8.8 [1.7-15.0] years), 630 patients (65.0%) developed MAKE-90. On multivariable analysis, cardiac comorbidity (adjusted odds ratio [aOR], 1.60; 95% CI, 1.08-2.37), longer duration of intensive care unit admission before CKRT initiation (aOR for 6 days vs 1 day, 1.07; 95% CI, 1.02-1.13), and liberation pattern were associated with MAKE-90. In this analysis, patients who successfully liberated from CKRT within 28 days had lower odds of MAKE-90 compared with patients in whom liberation was attempted and failed (aOR, 0.32; 95% CI, 0.22-0.48) and patients without a liberation attempt (aOR, 0.02; 95% CI, 0.01-0.04). Conclusions and Relevance In this study, MAKE-90 occurred in almost two-thirds of the population and patient-level risk factors associated with MAKE-90 included cardiac comorbidity, time to CKRT initiation, and liberation patterns. These findings highlight the high incidence of adverse outcomes in this population and suggest that future prospective studies are needed to better understand liberation patterns and practices.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Acute Kidney InjuryRenal DialysisAdolescentChildHumansMaleCohort StudiesKidneyRetrospective Studies

Autor:innen und Institutionen

  • University of Pittsburgh Medical Center Children's Hospital of Pittsburgh, Pittsburgh, Pennsylvania.
  • Children's Hospital Colorado, University of Colorado School of Medicine, Aurora.
  • University of Iowa Stead Family Children's Hospital, Carver College of Medicine, Iowa City.
  • University of Alberta, Edmonton, Canada.
  • Bambino Gesù Children's Hospital, IRCCS, Rome, Italy.
  • Gregorio Marañón University Hospital, School of Medicine, Madrid, Spain.

Förderung

  • NIGMS NIH HHS

Zitieren

APA

Fuhrman, D. Y., Stenson, E. K., Alhamoud, I., Alobaidi, R., Bottari, G., Fernandez, S., Guzzi, F., Haga, T., Kaddourah, A., Marinari, E., Mohamed, T. H., Morgan, C. J., Mottes, T., Neumayr, T. M., Ollberding, N. J., Raggi, V., Ricci, Z., See, E., Stanski, N. L., …, & WE-ROCK Investigators (2024). Major Adverse Kidney Events in Pediatric Continuous Kidney Replacement Therapy. JAMA Network Open. https://doi.org/10.1001/jamanetworkopen.2024.0243

Vancouver

Fuhrman DY, Stenson EK, Alhamoud I, Alobaidi R, Bottari G, Fernandez S, et al. Major Adverse Kidney Events in Pediatric Continuous Kidney Replacement Therapy. JAMA Network Open. 2024. doi:10.1001/jamanetworkopen.2024.0243

BibTeX
@article{Fuhrman2024,
  author = {Fuhrman, Dana Y and Stenson, Erin K and Alhamoud, Issa and Alobaidi, Rashid and Bottari, Gabriella and Fernandez, Sarah and Guzzi, Francesco and Haga, Taiki and Kaddourah, Ahmad and Marinari, Eleonora and Mohamed, Tahagod H and Morgan, Catherine J and Mottes, Theresa and Neumayr, Tara M and Ollberding, Nicholas J and Raggi, Valeria and Ricci, Zaccaria and See, Emily and Stanski, Natalja L and Zang, Huaiyu and Zangla, Emily and Gist, Katja M and WE-ROCK Investigators, WE-ROCK Investigators},
  title = {Major Adverse Kidney Events in Pediatric Continuous Kidney Replacement Therapy},
  journal = {JAMA Network Open},
  year = {2024},
  doi = {10.1001/jamanetworkopen.2024.0243}
}
Kostenlos starten →